Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state

Advances in Nutrition

Volumn 2, Issue 6, 2011, Pages 445-456

  Adams, Sean H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); AMINOTRANSFERASE; AROMATIC AMINO ACID; BRANCHED CHAIN AMINO ACID TRANSAMINASE; BRANCHED-CHAIN-AMINO-ACID TRANSAMINASE; CYSTEINE; CYSTINE; METHIONINE; PHENYLALANINE; SULFUR AMINO ACID; TYROSINE;

ANIMAL; BIOLOGICAL MODEL; HUMAN; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

3-METHYL-2-OXOBUTANOATE DEHYDROGENASE (LIPOAMIDE); AMINO ACIDS, AROMATIC; AMINO ACIDS, SULFUR; ANIMALS; CYSTEINE; CYSTINE; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; METHIONINE; MODELS, BIOLOGICAL; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHENYLALANINE; TRANSAMINASES; TYROSINE;

EID: 84862282554     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.111.000737     Document Type: Review

References (139)

1. Diaz VA, Mainous AG III, Baker R, Carnemolla M, Majeed A. How does ethnicity affect the association between obesity and diabetes? Diabet Med. 2007;24:1199-204.
2. Schauder P, Zavelberg D, Langer K, Herbertz L. Sex-specific differences in plasma branched-chain keto acid levels in obesity. Am J Clin Nutr. 1987;46:58-60.
3. Caballero B, Wurtman RJ. Differential effects of insulin resistance on leucine and glucose kinetics in obesity. Metabolism. 1991;40:51-8.
4. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311-26.
5. Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, Slentz CA, Tanner CJ, Kuchibhatla M, Houmard JA, Newgard CB, et al. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care. 2009;32:1678-83.
6. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH. Plasma metabolomic profiles reflective of glucose homeostasis in nondiabetic and type 2 diabetic obese African-American women. PLoS ONE. 2010;5:e15234.
7. Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, et al. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE. 2010;5:e10883.
8. Menge BA, Schrader H, Ritter PR, Ellrichmann M, Uhl W, Schmidt WE, Meier JJ. Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes. Regul Pept. 2010;160:75-80.
9. Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, Goh DL, Ilkayeva OR, Wenner BR, Bain JR, Lee JJ, et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia. 2010;53:757-67.
10. Adibi SA. Influence of dietary deprivations on plasma concentration of free amino acids of man. J Appl Physiol. 1968;25:52-7.
11. Felig P, Marliss E, Cahill GF Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med. 1969;281:811-6.
12. Zeng M, Liang Y, Li H, Wang M, Wang B, Chen X, Zhou N, Cao D, Wu J. Plasma metabolic fingerprinting of childhood obesity by GC/MS in conjunction with multivariate statistical analysis. J Pharm Biomed Anal. 2010;52:265-72.
13. Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol. 2004;82:506-14.
14. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab. 2007;293:E1552-63.
15. Kuzuya T, Katano Y, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Honda T, Goto H, Fujita Y, et al. Regulation of branchedchain amino acid catabolism in rat models for spontaneous type 2 diabetes mellitus. Biochem Biophys Res Commun. 2008;373:94-8.
16. Bajotto G, Murakami T, Nagasaki M, Sato Y, Shimomura Y. Decreased enzyme activity and contents of hepatic branched-chain alpha-keto acid dehydrogenase complex subunits in a rat model for type 2 diabetes mellitus. Metabolism. 2009;58:1489-95.
17. Doisaki M, Katano Y, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Goto H, Fujita Y, Kadota Y, et al. Regulation of hepatic branched-chain alpha-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. Biochem Biophys Res Commun. 2010;393:303-7.
18. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448-53.
19. El-Khairy L, Ueland PM, Nygard O, Refsum H, Vollset SE. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr. 1999;70:1016-24.
20. El-Khairy L, Vollset SE, Refsum H, Ueland PM. Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study. Clin Chem. 2003;49:113-20.
21. Elshorbagy AK, Nurk E, Gjesdal CG, Tell GS, Ueland PM, Nygard O, Tverdal A, Vollset SE, Refsum H. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Am J Clin Nutr. 2008;88: 738-46.
22. Elshorbagy AK, Refsum H, Smith AD, Graham IM. The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity. Obesity (Silver Spring). 2009;17:1435-40.
23. Marchesini G, Bianchi GP, Vilstrup H, Capelli M, Zoli M, Pisi E. Elimination of infused branched-chain amino-acids from plasma of patients with non-obese type 2 diabetes mellitus. Clin Nutr. 1991;10: 105-13.
24. Gougeon R, Pencharz PB, Sigal RJ. Effect of glycemic control on the kinetics of whole-body protein metabolism in obese subjects with non-insulin-dependent diabetes mellitus during iso-and hypoenergetic feeding. Am J Clin Nutr. 1997;65:861-70.
25. Gougeon R, Marliss EB, Jones PJ, Pencharz PB, Morais JA. Effect of exogenous insulin on protein metabolism with differing nonprotein energy intakes in Type 2 diabetes mellitus. Int J Obes Relat Metab Disord. 1998;22:250-61.
26. Gougeon R, Styhler K, Morais JA, Jones PJ, Marliss EB. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care. 2000;23:1-8.
27. Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB. Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care. 2008;31:128-33.
28. Glass AR, Bongiovanni R, Smith CE, Boehm TM. Normal valine disposal in obese subjects with impaired glucose disposal: evidence for selective insulin resistance. Metabolism. 1981;30:578-82.
29. Umpleby AM, Scobie IN, Boroujerdi MA, Carson ER, Sonksen PH. Diurnal variation in glucose and leucine metabolism in non-insulindependent diabetes. Diabetes Res Clin Pract. 1990;9:89-96.
30. Halvatsiotis PG, Turk D, Alzaid A, Dinneen S, Rizza RA, Nair KS. Insulin effect on leucine kinetics in type 2 diabetes mellitus. Diabetes Nutr Metab. 2002;15:136-42.
31. Halvatsiotis P, Short KR, Bigelow M, Nair KS. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes. 2002;51:2395-404.
32. Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes. 2008;57: 56-63.
33. Guillet C, Delcourt I, Rance M, Giraudet C, Walrand S, Bedu M, Duche P, Boirie Y. Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab. 2009;94:3044-50.
34. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol. 2008;4:214.
35. Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, Minkler PE, Hwang DH, Newman JW, Garvey WT. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr. 2009;139:1073-81.
36. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008;7:45-56.
37. Tessari P, Nissen SL, Miles JM, Haymond MW. Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest. 1986;77:575-81.
38. Lowell BB, Goodman MN. Protein sparing in skeletal muscle during prolonged starvation. Dependence on lipid fuel availability. Diabetes. 1987;36:14-9.
39. GoodmanMN, Larsen PR, Kaplan MM, Aoki TT, Young VR, Ruderman NB. Starvation in the rat. II. Effect of age and obesity on protein sparing and fuel metabolism. Am J Physiol. 1980;239:E277-86.
40. Henry CJ, Rivers JP, Payne PR. Protein and energy metabolism in starvation reconsidered. Eur J Clin Nutr. 1988;42:543-9.
41. Dulloo AG, Jacquet J, Solinas G, Montani JP, Schutz Y. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond). 2010;34 SUPPL 2:S4-17.
42. Gougeon R, Pencharz PB, Marliss EB. Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes. 1994;43:318-28.
43. Staten MA, Matthews DE, Bier DM. Leucine metabolism in type II diabetes mellitus. Diabetes. 1986;35:1249-53.
44. Hoffer LJ, TaveroffA, Hamadeh MJ. Dietary protein restriction alters glucose but not protein metabolism in non-insulin-dependent diabetes mellitus. Metabolism. 1998;47:1145-51.
45. Islam MM, Wallin R, Wynn RM, Conway M, Fujii H, Mobley JA, Chuang DT, Hutson SM. A novel branched-chain amino acid metabolon. Protein-protein interactions in a supramolecular complex. J Biol Chem. 2007;282:11893-903.
46. Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr. 1998;68:72-81.
47. Sweatt AJ, Wood M, Suryawan A, Wallin R, Willingham MC, Hutson SM. Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves. Am J Physiol Endocrinol Metab. 2004;286:E64-76.
48. Wohlhueter RM, Harper AE. Coinduction of rat liver branched chain alpha-keto acid dehydrogenase activities. J Biol Chem. 1970;245:2391-401.
49. Johnson WA, Connelly JL. Cellular localization and characterization of bovine liver branched-chain -keto acid dehydrogenases. Biochemistry. 1972;11:1967-73.
50. Parker PJ, Randle PJ. Partial purification and properties of branchedchain 2-oxo acid dehydrogenase of ox liver. Biochem J. 1978;171:751-7.
51. Paxton R, Scislowski PW, Davis EJ, Harris RA. Role of branched-chain 2-oxo acid dehydrogenase and pyruvate dehydrogenase in 2-oxobutyrate metabolism. Biochem J. 1986;234:295-303.
52. Obayashi M, Sato Y, Harris RA, Shimomura Y. Regulation of the activity of branched-chain 2-oxo acid dehydrogenase (BCODH) complex by binding BCODH kinase. FEBS Lett. 2001;491:50-4.
53. XuM, NagasakiM, ObayashiM, Sato Y, Tamura T, Shimomura Y. Mechanism of activation of branched-chain alpha-keto acid dehydrogenase complex by exercise. Biochem Biophys Res Commun. 2001;287:752-6.
54. Paul HS, Liu WQ, Adibi SA. Alteration in gene expression of branched-chain keto acid dehydrogenase kinase but not in gene expression of its substrate in the liver of clofibrate-treated rats. Biochem J. 1996;317:411-7.
55. Kobayashi R, Murakami T, Obayashi M, Nakai N, Jaskiewicz J, Fujiwara Y, Shimomura Y, Harris RA. Clofibric acid stimulates branched-chain amino acid catabolism by three mechanisms. Arch Biochem Biophys. 2002;407:231-40.
56. Paxton R, Harris RA. Regulation of branched-chain alpha-ketoacid dehydrogenase kinase. Arch Biochem Biophys. 1984;231:48-57.
57. Nellis MM, Doering CB, Kasinski A, Danner DJ. Insulin increases branched-chain alpha-ketoacid dehydrogenase kinase expression in Clone 9 rat cells. Am J Physiol Endocrinol Metab. 2002;283:E853-60.
58. Harris RA, Kobayashi R, Murakami T, Shimomura Y. Regulation of branched-chain alpha-keto acid dehydrogenase kinase expression in rat liver. J Nutr. 2001;131:S841-5.
59. Shimomura Y, Obayashi M, Murakami T, Harris RA. Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain alpha-keto acid dehydrogenase kinase. Curr Opin Clin NutrMetab Care. 2001;4:419-23.
60. Joshi M, Jeoung NH, Popov KM, Harris RA. Identification of a novel PP2C-type mitochondrial phosphatase. Biochem Biophys Res Commun. 2007;356:38-44.
61. Lu G, Sun H, She P, Youn JY, Warburton S, Ping P, Vondriska TM, Cai H, Lynch CJ, Wang Y. Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest. 2009;119:1678-87.
62. Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem. 2010;285:11348-56.
63. Jones SM, Yeaman SJ. Phosphorylation of branched-chain 2-oxo acid dehydrogenase complex in isolated adipocyte. Effects of 2-oxo acids. Biochem J. 1986;236:209-13.
64. Papet I, Lezebot N, Barre F, Arnal M, Harper AE. Influence of dietary leucine content on the activities of branched-chain amino acid aminotransferase (EC 2.6.1.42) and branched-chain alpha-keto acid dehydrogenase (EC 1.2.4.4) complex in tissues of preruminant lambs. Br J Nutr. 1988;59:475-83.
65. Laferrere B, Reilly D, Arias S, Swerdlow N, Gorroochurn P, Bawa B, Bose M, Teixeira J, Stevens RD, Wenner BR, et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med. 2011;3:80re2.
66. Brosnan JT, Brosnan ME. Branched-chain amino acids: enzyme and substrate regulation. J Nutr. 2006;136:S207-11.
67. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007;29:99-108.
68. Li X, Xu Z, Lu X, Yang X, Yin P, Kong H, Yu Y, Xu G. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: biomarker discovery for diabetes mellitus. Anal Chim Acta. 2009;633:257-62.
69. Macotela Y, Emanuelli B, Bang AM, Espinoza DO, Boucher J, Beebe K, Gall W, Kahn CR. Dietary leucine-an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS ONE. 2011;6:e21187.
70. Pettit FH, Yeaman SJ, Reed LJ. Purification and characterization of branched chain alpha-keto acid dehydrogenase complex of bovine kidney. Proc Natl Acad Sci USA. 1978;75:4881-5.
71. Jones SM, Yeaman SJ. Oxidative decarboxylation of 4-methylthio-2-oxobutyrate by branched-chain 2-oxo acid dehydrogenase complex. Biochem J. 1986;237:621-3.
72. Steele RD, Weber H, Patterson JI. Characterization of alpha-ketobutyrate metabolism in rat tissues: effects of dietary protein and fasting. J Nutr. 1984;114:701-10.
73. Bremer J. Pyruvate dehydrogenase, substrate specificity and product inhibition. Eur J Biochem. 1969;8:535-40.
74. Kanzaki T, Hayakawa T, Hamada M, Fukuyoshi Y, Koike M. Mammalian alpha-keto acid dehydrogenase complexe. IV. Substrate specificities and kinetic properties of the pig heart pyruvate and 2-oxyoglutarate dehydrogenase complexes. J Biol Chem. 1969;244:1183-7.
75. Borud O, Pettersen JE. Normal 2-aminobutyrate oxidation and increased valine oxidation in fibroblasts deficient in pyruvate dehydrogenase. J Inherit Metab Dis. 1982;5:55-7.
76. Smith AJ, Strang LB. An inborn error of metabolism with the urinary excretion of alpha-hydroxy-butyric acid and phenylpyruvic acid. Arch Dis Child. 1958;33:109-13.
77. Jakobs C, Solem E, Ek J, Halvorsen K, Jellum E. Investigation of the metabolic pattern in maple syrup urine disease by means of glass capillary gas chromatography and mass spectrometry. J Chromatogr A. 1977;143:31-8.
78. Okuda Y, Kawai K, Murayama Y, Yamashita K. Postprandial changes in plasma ketone body and carnitine levels in normal and non-insulindependent diabetic subjects. Endocrinol Jpn. 1987;34:415-22.
79. Ubukata E. Diurnal variation of blood ketone bodies in insulindependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin. Ann Nutr Metab. 1990;34:333-42.
80. Robertson DA, Singh BM, Nattrass M. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance. Int J Obes. 1991;15:635-45.
81. Avogaro A, Crepaldi C, Miola M, Maran A, Pengo V, Tiengo A, Del Prato S. High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. J Endocrinol Invest. 1996;19:99-105.
82. Holness MJ, Sugden MC. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans. 2003; 31:1143-51.
83. Ido Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid Redox Signal. 2007;9:931-42.
84. Kawasaki T, Akanuma H, Yamanouchi T. Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002;25:353-7.
85. Gillim SE, Paxton R, Cook GA, Harris RA. Activity state of the branched chain alpha-ketoacid dehydrogenase complex in heart, liver, and kidney of normal, fasted, diabetic, and protein-starved rats. Biochem Biophys Res Commun. 1983;111:74-81.
86. Randle PJ. alpha-Ketoacid dehydrogenase complexes and respiratory fuel utilisation in diabetes. Diabetologia. 1985;28:479-84.
87. Boyer B, Odessey R. Quantitative control analysis of branched-chain 2-oxo acid dehydrogenase complex activity by feedback inhibition. Biochem J. 1990;271:523-8.
88. Boyer B, Odessey R. Kinetic characterization of branched chain ketoacid dehydrogenase. Arch Biochem Biophys. 1991;285:1-7.
89. Williamson JR, Walajtys-Rode E, Coll KE. Effects of branched chain alpha-ketoacids on the metabolism of isolated rat liver cells. I. Regulation of branched chain alpha-ketoacid metabolism. J Biol Chem. 1979;254:11511-20.
90. Hu H, Jaskiewicz JA, Harris RA. Ethanol and oleate inhibition of alpha-ketoisovalerate and 3-hydroxyisobutyrate metabolism by isolated hepatocytes. Arch Biochem Biophys. 1992;299:57-62.
91. Okita M, Watanabe A, Shiota T, Nagashima H. Plasma level of branched chain alpha-amino acids following its alpha-keto acid administration to rats. J Nutr Sci Vitaminol (Tokyo). 1986;32:83-91.
92. Ciman M, Carignani G, Alexandre A, Siliprandi N. On the inhibition of -oxobutyrate utilization by fatty acids in rat liver mitochondria. Biochim Biophys Acta. 1971;253:24-8.
93. Xue GP, Snoswell AM. Disturbance of methyl group metabolism in alloxan-diabetic sheep. Biochem Int. 1985;10:897-905.
94. Hargrove JL, Trotter JF, Ashline HC, Krishnamurti PV. Experimental diabetes increases the formation of sulfane by transsulfuration and inactivation of tyrosine aminotransferase in cytosols from rat liver. Metabolism. 1989;38:666-72.
95. Wijekoon EP, Brosnan ME, Brosnan JT. Homocysteine metabolism in diabetes. Biochem Soc Trans. 2007;35:1175-9.
96. Buckley WT, Milligan LP. Participation of cysteine and cystine in inactivation of tyrosine aminotransferase in rat liver homogenates. Biochem J. 1978;176:449-54.
97. Hargrove JL, Wichman RD. A cystine-dependent inactivator of tyrosine aminotransferase co-purifies with gamma-cystathionase (cystine desulfurase). J Biol Chem. 1987;262:7351-7.
98. Hargrove JL. Persulfide generated from L-cysteine inactivates tyrosine aminotransferase. Requirement for a protein with cysteine oxidase activity and gamma-cystathionase. J Biol Chem. 1988;263:17262-9.
99. Reynolds RD. Vitamin B-6 requirement for irreversible inactivation of rat liver tyrosine aminotransferase. Arch Biochem Biophys. 1978;186: 324-34.
100. Sloger MS, Scholfield LG, Reynolds RD. Loss of in vitro inactivation of rat liver tyrosine aminotransferase with dietary vitamin B6 restriction. J Nutr. 1978;108:1355-60.
101. Feng X, Chen Y, Zhao J, Tang C, Jiang Z, Geng B. Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun. 2009;380:153-9.
102. Jacobs RL, Stead LM, Brosnan ME, Brosnan JT. Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver. J Biol Chem. 2001; 276:43740-7.
103. Block KP, Heywood BW, Buse MG, Harper AE. Activation of rat liver branched-chain 2-oxo acid dehydrogenase in vivo by glucagon and adrenaline. Biochem J. 1985;232:593-7.
104. Block KP, Soemitro S, Heywood BW, Harper AE. Activation of liver branched-chain alpha-keto acid dehydrogenase in rats by excesses of dietary amino acids. J Nutr. 1985;115:1550-61.
105. Aftring RP, Block KP, Buse MG. Leucine and isoleucine activate skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo. Am J Physiol. 1986;250:E599-604.
106. Crowell PL, Block KP, Repa JJ, Torres N, Nawabi MD, Buse MG, Harper AE. High branched-chain alpha-keto acid intake, branched-chain alpha-keto acid dehydrogenase activity, and plasma and brain amino acid and plasma keto acid concentrations in rats. Am J Clin Nutr. 1990;52:313-9.
107. Tremblay F, Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem. 2001; 276:38052-60.
108. Doi M, Yamaoka I, Fukunaga T, Nakayama M. Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes. Biochem Biophys Res Commun. 2003;312:1111-7.
109. Tzatsos A, Kandror KV. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol. 2006;26:63-76.
110. Hinault C, Mothe-Satney I, Gautier N, Lawrence JC Jr, Van Obberghen E. Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice. FASEB J. 2004;18:1894-6.
111. Hinault C, Van Obberghen E, Mothe-Satney I. Role of amino acids in insulin signaling in adipocytes and their potential to decrease insulin resistance of adipose tissue. J Nutr Biochem. 2006;17:374-8.
112. Korsheninnikova E, van der Zon GC, Voshol PJ, Janssen GM, Havekes LM, Grefhorst A, Kuipers F, Reijngoud DJ, Romijn JA, Ouwens DM, et al. Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia. 2006;49:3049-57.
113. Noatsch A, Petzke KJ, Millrose MK, Klaus S. Body weight and energy homeostasis was not affected in C57BL/6 mice fed high whey protein or leucine-supplemented low-fat diets. Eur J Nutr. 2011;50:479-88.
114. D'Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, Bruttini F, Caliaro F, Corsetti G, Bottinelli R, Carruba MO, et al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab. 2010;12:362-72.
115. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J. 2000;14:1132-8.
116. Eller LK, Reimer RA. Dairy protein attenuates weight gain in obese rats better than whey or casein alone. Obesity (Silver Spring). 2010; 18:704-11.
117. Papakonstantinou E, Flatt WP, Huth PJ, Harris RB. High dietary calcium reduces body fat content, digestibility of fat, and serum vitamin D in rats. Obes Res. 2003;11:387-94.
118. Pilvi TK, Korpela R, Huttunen M, Vapaatalo H, Mervaala EM. Highcalcium diet with whey protein attenuates body-weight gain in highfat-fed C57Bl/6J mice. Br J Nutr. 2007;98:900-7.
119. Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes. 2007;56:1647-54.
120. Parra P, Bruni G, Palou A, Serra F. Dietary calcium attenuation of body fat gain during high-fat feeding in mice. J Nutr Biochem. 2008;19:109-17.
121. Shertzer HG, Woods SE, Krishan M, Genter MB, Pearson KJ. Dietary whey protein lowers the risk for metabolic disease in mice fed a highfat diet. J Nutr. 2011;141:582-7.
122. Kettelhut IC, Foss MC, Migliorini RH. Lipolysis and the antilipolytic effect of insulin in adipocytes from rats adapted to a high-protein diet. Metabolism. 1985;34:69-73.
123. Guo K, Yu YH, Hou J, Zhang Y. Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitus. Nutr Metab (Lond). 2010;7:57.
124. Gannon MC, Nuttall FQ, Saeed A, Jordan K, Hoover H. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. Am J Clin Nutr. 2003;78:734-41.
125. Nuttall FQ, Schweim K, Hoover H, Gannon MC. Effect of the LoBAG30 diet on blood glucose control in people with type 2 diabetes. Br J Nutr. 2008;99:511-9.
126. Gannon MC, Hoover H, Nuttall FQ. Further decrease in glycated hemoglobin following ingestion of a LoBAG30 diet for 10 weeks compared to 5 weeks in people with untreated type 2 diabetes. Nutr Metab (Lond). 2010;7:64.
127. Brinkworth GD, Noakes M, Parker B, Foster P, Clifton PM. Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial. Diabetologia. 2004;47: 1677-86.
128. Sargrad KR, Homko C, Mozzoli M, Boden G. Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus. J Am Diet Assoc. 2005;105:573-80.
129. Larsen RN, Mann NJ, Maclean E, Shaw JE. The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial. Diabetologia. 2011;54:731-40.
130. Zemel MB, Sun X, Sobhani T, Wilson B. Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Am J Clin Nutr. 2010;91:16-22.
131. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350:664-71.
132. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, Neschen S, White MF, Bilz S, Sono S, et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest. 2005;115:3587-93.
133. Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL, Shulman GI. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes. 2007;56:1376-81.
134. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes. 2005;54:8-14.
135. Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, Beck-Nielsen H, Hojlund K. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes. 2007;56: 1592-9.
136. Khatra BS, Chawla RK, Wadsworth AD, Rudman D. Effect of dietary branched-chain alpha-keto acids on hepatic branched-chain alphaketo acid dehydrogenase in the rat. J Nutr. 1977;107:1528-36.
137. Dixon JL, Harper AE. Effects on plasma amino acid concentrations and hepatic branched-chain alpha-keto acid dehydrogenase activity of feeding rats diets containing 9 or 50% casein. J Nutr. 1984;114: 1025-34.
138. Sears DD, Hsiao G, Hsiao A, Yu JG, Courtney CH, Ofrecio JM, Chapman J, Subramaniam S. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci USA. 2009;106:18745-50.
139. Hsiao G, Chapman J, Ofrecio JM, Wilkes J, Resnik JL, Thapar D, Subramaniam S, Sears DD. Multi-tissue, selective PPARgamma modulation of insulin sensitivity and metabolic pathways in obese rats. Am J Physiol Endocrinol Metab. 2011;300:E164-74.